Deborah A. Mulford, M.D.

Deborah A. Mulford, M.D.

Contact Information

University of Rochester Medical Center
School of Medicine and Dentistry
601 Elmwood Ave, Box 704
Rochester, NY 14642

Office: (585) 275-5823
Fax: (585) 273-1042
Administrative: (585) 275-9319


The biographical information for Deborah A. Mulford, M.D. is not currently available.

Awards & Honors (National)

NIH Clinical Loan Repayment Program | NIH 2004 - 2006

Awards & Honors (Local)

Lauri Strauss Leukemia Foundation Endowed Fellowship | Lauri Strauss Leukemia Foundation | Memorial Sloan-Kettering Cancer Center, New York City, NY 2003 - 2005
Mortimer J. Lacher Fellowship Award | Memorial Sloan-Kettering Cancer Center, New York City, NY 2003 - 2005
International Cancer Fellowship | University of Rochester Medical School | Rochester, NY 1996 - 1996
U.S. and European Patent-Photographic Apparatus for an Optical Instrument | Polaroid Corporation, Boston, MA 1991
Warner King Prize | Union College, Schenectady, NY 1990
Stearns Prize | Union College, Schenectady, NY 1989 - 1990
Eta Kappa Nu and Tau Beta Pi Engineering Honor Societies | Union College, Schenectady, NY 1988 - 1990
Tidmarsh Scholarship for Piano | Union College, Schenectady, NY 1986 - 1990

Recent Journal Articles

Showing the 5 most recent journal articles. 10 available »

2012 Apr 15
Raza A, Galili N, Smith SE, Godwin J, Boccia RV, Myint H, Mahadevan D, Mulford D, Rarick M, Brown GL, Schaar D, Faderl S, Komrokji RS, List AF, Sekeres M. "A phase 2 randomized multicenter study of 2 extended dosing schedules of oral ezatiostat in low to intermediate-1 risk myelodysplastic syndrome." Cancer. 2012 Apr 15; 118(8):2138-47. Epub 2011 Sep 01.
2011 Aug
Liesveld JL, Rosell KE, Bechelli J, Lu C, Messina P, Mulford D, Ifthikharuddin JJ, Jordan CT, Phillips Ii GL. "Proteasome inhibition in myelodysplastic syndromes and acute myelogenous leukemia cell lines." Cancer investigation. 2011 Aug; 29(7):439-50.
2011 Jul 21
Sekeres MA, Gundacker H, Lancet J, Advani A, Petersdorf S, Liesveld J, Mulford D, Norwood T, Willman CL, Appelbaum FR, List AF. "A phase 2 study of lenalidomide monotherapy in patients with deletion 5q acute myeloid leukemia: Southwest Oncology Group Study S0605." Blood. 2011 Jul 21; 118(3):523-8. Epub 2011 May 06.
2010 Nov 1
Rosenblat TL, McDevitt MR, Mulford DA, Pandit-Taskar N, Divgi CR, Panageas KS, Heaney ML, Chanel S, Morgenstern A, Sgouros G, Larson SM, Scheinberg DA, Jurcic JG. "Sequential cytarabine and alpha-particle immunotherapy with bismuth-213-lintuzumab (HuM195) for acute myeloid leukemia." Clinical cancer research : an official journal of the American Association for Cancer Research. 2010 Nov 1; 16(21):5303-11. Epub 2010 Sep 21.
2008 Dec
Walker AR, Komrokji RS, Ifthikharuddin J, Messina P, Mulford D, Becker M, Friedberg J, Oliva J, Phillips G, Liesveld JL, Abboud C. "Phase I study of cladribine, cytarabine (Ara-C), granulocyte colony stimulating factor (G-CSF) (CLAG Regimen) and simultaneous escalating doses of imatinib mesylate (Gleevec) in relapsed/refractory AML." Leukemia research. 2008 Dec; 32(12):1830-6. Epub 2008 Jun 20.

Current Appointments

Associate Professor of Clinical Medicine - Department of Medicine, Hematology/Oncology (SMD) - Primary


Internal Medicine - American Board of Internal Medicine
Medical Oncology - American Board of Internal Medicine
Hematology - American Board of Internal Medicine


MD | Medicine | Univ Rochester Sch Med/Dent1999
BS | Electrical Engineering | Union College1990
Post-baccalaureate program | Harvard UniversityAttended 1992 - 1994

Post-Doctoral Training & Residency

Fellowship in Hematology/Oncology at Memorial Sloan-Kettering Cancer Center07/01/2002 - 06/30/2005
Residency in Internal Medicine at New York University School of Medicine07/01/2000 - 06/30/2002
Internship in Internal Medicine at New York University School of Medicine07/01/1999 - 06/30/2000